HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis

Idanna InnocentiInstitute of Hematology, Università Cattolica del Sacro Cuore, Roma, Italy;

Francesca MorelliInstitute of Hematology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy; ;Institute of Internal Medicine, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy;

Francesco AutoreInstitute of Hematology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy; ;Institute of Internal Medicine, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy;

Andrea CorbingiInstitute of Hematology, Università Cattolica del Sacro Cuore, Roma, Italy;

Raffaella PasqualeFondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, Institute of Hematology, Milano, Italy;

Federica SoràInstitute of Hematology, Università Cattolica del Sacro Cuore, Roma, Italy;

Maurizio PompiliInstitute of Internal Medicine, Università Cattolica del Sacro Cuore, Roma, Italy

Luca LaurentiInstitute of Hematology, Università Cattolica del Sacro Cuore, Roma, Italy; Correspondence[email protected]

show all

Click to increase image sizeClick to decrease image size

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at http://dx.doi.org/10.1080/10428194.2018.1523401.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis

Information for

Open access

Opportunities

Help and information

HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis

Potential conflict of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature